Peer-Delivered, Behavioral Activation Intervention to Improve Polysubstance Use and Retention in Mobile Telemedicine OUD Treatment in an Underserved, Rural Area
同伴提供的行为激活干预可改善服务不足的农村地区移动远程医疗 OUD 治疗中多物质的使用和保留
基本信息
- 批准号:10578063
- 负责人:
- 金额:$ 235.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2025-09-29
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAddressAdherenceAdoptionAppointmentAreaBehavior TherapyBehavioralBuprenorphineCaringCommunitiesEffectivenessEnvironmentEvidence based interventionHealthHealth Care SectorHealth PersonnelIndividualIntakeInterventionLeadLeftMarylandMedicalMedically Underserved AreaMethodsModelingNursesOutcomePatientsPersonsPharmaceutical PreparationsPharmacy facilityPopulationPositive ReinforcementsProctor frameworkProfessional counselorProviderPsychological reinforcementRandomizedReach Effectiveness Adoption Implementation and MaintenanceRecoveryRecovery SupportResourcesRewardsRuralRural CommunityRural PopulationServicesSiteSpecialistSubstance Use DisorderTelemedicineTrainingUrinalysisWorkacceptability and feasibilityaddictionbasecommunity settingcontingency managementcostcost effectivenessdesigneconomic valueeffectiveness evaluationeffectiveness implementation studyeffectiveness implementation trialeffectiveness outcomeexperiencefree behaviorimplementation costimplementation evaluationimplementation outcomesimprovednon-opioid analgesicopioid overdoseopioid useopioid use disorderpeerpeer supportpolysubstance useprimary outcomeprovider-level barriersrural Americarural arearural countiesrural underservedstimulant usestimulant use disordersubstance usetreatment as usualtreatment servicesunderserved areaunderserved rural areaurban areavirtualwaiver
项目摘要
Background. More than 50% of rural counties in the US do not have a single buprenorphine-waived provider,
and approximately 10% of people in the US live more than 10 miles away from their nearest prescriber.
Compounding the devastating effects of the opioid use disorder (OUD) crisis in underserved, rural areas is
increasing polysubstance use, notably stimulant use disorder co-occurring with OUD. Since 2019, our team
has filled a void of rural addiction treatment practitioners in underserved rural Maryland areas by providing
buprenorphine for OUD treatment with the use of telemedicine (TM) aboard a mobile treatment unit (MTU). Our
team has demonstrated the effectiveness of the TM-MTU model in reducing opioid use by 32.8% at three-
months. Yet, 92% of patients in the past year presented with polysubstance use at intake, approximately
half with OUD and stimulant use. Further, treatment retention is a challenge, amplified by polysubstance use;
less than 60% of patients were retained at three-months. Reinforcement-based approaches, such as
contingency management, have empirical support for improving treatment retention and stimulant use, yet
have low adoption in community settings due to organizational and provider barriers, including cost. A
behavioral reinforcement-based approach, such as behavioral activation (BA), which aims to increase positive
reinforcement through rewarding, substance-free behaviors, may be a promising effective and sustainable
strategy to improve both OUD treatment retention and polysubstance use, particularly stimulant use. Further,
our team has demonstrated that it is feasible to train peer recovery specialists (PRSs) in BA. Preliminary
Studies. This proposal builds upon our team’s prior studies demonstrating the feasibility, acceptability, and
effectiveness of: 1) the TM-MTU model reaching rural communities hard hit by the OUD crisis and
polysubstance use; 2) integrating PRS support on the TM-MTU; and 3) a PRS-delivered BA intervention (“Peer
Activate”) for improving treatment retention and reducing polysubstance use, including OUD and stimulant use.
Approach. Building upon this work, we propose a randomized Type 1 hybrid effectiveness-implementation trial
(n=180) to evaluate the PRS-delivered BA intervention on the MTU (Peer Activate-MTU) compared to
enhanced treatment as usual (ETAU; facilitated referrals and general peer support) on the following over 12-
months: (1) effectiveness outcomes: a) OUD treatment retention (primary: chart review of appointment
attendance); b) polysubstance use (co-primary: urinalysis of co-occurring use of ≥2 substances); and c)
buprenorphine adherence (secondary: urinalysis and pharmacy refill); (2) implementation outcomes, including
feasibility, acceptability, fidelity, and adoption guided by RE-AIM; (3) cost of implementing and sustaining Peer
Activate-MTU and its economic value relative to ETAU. Implications. This proposal is designed to lead to a
potentially scalable model for improving OUD treatment retention and polysubstance use, particularly co-
occurring OUD and stimulant use, and increasing the reach of addiction treatment in underserved, rural areas.
背景。美国超过50%的农村县没有一家丁丙诺啡豁免供应商,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah M. Kattakuzhy其他文献
Sarah M. Kattakuzhy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah M. Kattakuzhy', 18)}}的其他基金
CJ-PRISM: Understanding the Impact of Criminolegal System Involvement on a Peer-Delivered Intervention to Improve Retention and Polysubstance Use
CJ-PRISM:了解刑事法律系统的参与对同行提供的干预措施的影响,以改善保留和多物质使用
- 批准号:
10841123 - 财政年份:2023
- 资助金额:
$ 235.79万 - 项目类别:
Evaluating the role of stigma in polysubstance use and medication for opioid use disorder treatment in an underserved, rural setting
评估在服务不足的农村环境中耻辱在多种物质使用和阿片类药物使用障碍治疗药物中的作用
- 批准号:
10838077 - 财政年份:2022
- 资助金额:
$ 235.79万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 235.79万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 235.79万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 235.79万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 235.79万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 235.79万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 235.79万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 235.79万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 235.79万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 235.79万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 235.79万 - 项目类别: